Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis

Drakopanagiotakis, F., Xifteri, A., Tsiambas, E., Karameris, A., Tsakanika, K., Karagiannidis, N., Mermigkis, D., Polychronopoulos, V., & Bouros, D. (2012). Decreased Apoptotic Rate of Alveolar Macrophages of Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Medicine, 2012(), 764-772. https://doi.org/10.1155/2012/981730
Inghilleri, S., Morbini, P., Campo, I., Zorzetto, M., Oggionni, T., Pozzi, E., & Luisetti, M. (2011). Factors Influencing Oxidative Imbalance in Pulmonary Fibrosis: An Immunohistochemical Study. Pulmonary Medicine, 2011(), 128-137. https://doi.org/10.1155/2011/421409
Fan, L., Yu, X., Huang, Z., Zheng, S., Zhou, Y., Lv, H., Zeng, Y., Xu, J. F., Zhu, X., & Yi, X. (2017). Analysis of Microarray-Identified Genes and MicroRNAs Associated with Idiopathic Pulmonary Fibrosis. Mediators of Inflammation, 2017(), 1-9. https://doi.org/10.1155/2017/1804240
Yoshifuji, H. (2015). Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, (2015-S1), 141-146. https://doi.org/10.4137/CCRPM.S36748
Tzouvelekis, A., Bouros, E., Oikonomou, A., Ntolios, P., Zacharis, G., Kolios, G., & Bouros, D. (2011). Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis. Pulmonary Medicine, 2011(), 292-298. https://doi.org/10.1155/2011/849035